Aerovate Therapeutics Overview
Aerovate Therapeutics Discounted Cash Flow
DCF Analysis for AVTE.
Get informed when a big investor buys or sells
+ FollowFair Value
$1.17
Current Fair Value
$1.17
↓ 56.5% Downside
Overvalued by 56.5% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison